U.S. SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                             ----------------------

                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934


         Date of Report (Date of earliest event reported) April 27, 2006


                         Diagnostic Products Corporation
                         -------------------------------
             (Exact name of Registrant as specified in its charter)

        California                      1-9957                  95-2802182
        ----------                      ------                  ----------
(State or other jurisdiction          (Commission              (IRS Employer
     of incorporation)                File Number)           Identification No.)


        5210 Pacific Concourse Drive, Los Angeles, California 90045-6900
        ----------------------------------------------------------------
               (Address of principal executive offices) (Zip Code)

                                 (310) 645-8200
              ----------------------------------------------------
              (Registrant's telephone number, including area code)



Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[_]  Written communications pursuant to Rule 425 under the Securities
     Act (17 CFR 230.425)

[_]  Soliciting material pursuant to Rule 14a-12 under the Exchange
     Act (17 CFR 240.14a-12)

[_]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[_]  Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13e-4(c))





                         Diagnostic Products Corporation
                           Current Report on Form 8-K


ITEM 2.02.   RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

     On April 27, 2006, Diagnostic Products Corporation announced its results of
operations for the quarter ended March 31, 2006. A copy of the related press
release is being furnished as Exhibit 99.1 to this Form 8-K and is incorporated
herein by reference in its entirety.



ITEM 9.01    FINANCIAL STATEMENTS AND EXHIBITS.

(c)   Exhibits.

      No. 99.1    Press Release issued by Diagnostic Products Corporation, dated
                  April 27, 2006.


                                   SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Dated: April 27, 2006                          Diagnostic Products Corporation




                                               By: /s/ James L. Brill
                                                   --------------------------
                                                   James L. Brill,
                                                   Vice President, Finance


                                       2



                                  EXHIBIT INDEX

Exhibit Number
- --------------

     99.1           Press Release issued by Diagnostic Products Corporation,
                    dated April 27, 2006.


                                       3